Literature DB >> 17907149

Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients.

Mirko Manetti1, Elena Neumann, Anna Franca Milia, Ingo H Tarner, Paolo Bechi, Marco Matucci-Cerinic, Lidia Ibba-Manneschi, Ulf Müller-Ladner.   

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is a connective tissue disorder characterized by fibrosis of the skin and internal organs. Although the esophagus is the most frequently affected part of the gastrointestinal tract, all other segments can be involved. The present study was undertaken to evaluate the fibrotic process and the expression of fibrogenic cytokines in the gastric wall of SSc patients with gastroesophageal involvement.
METHODS: Full-thickness surgical and endoscopic gastric biopsy samples were obtained from 14 SSc patients and 10 controls. Tissue sections were either stained with Masson's trichrome or by immunohistochemistry and analyzed for the expression of types I, III, and IV collagen, alpha-smooth muscle actin (alpha-SMA), transforming growth factor beta (TGFbeta), connective tissue growth factor (CTGF), and endothelin 1 (ET-1).
RESULTS: In the gastric wall of SSc patients, Masson's trichrome staining and immunohistochemistry for types I and III collagen revealed a high amount of collagen in the lamina propria that increased toward the muscularis mucosae. In addition, muscle layers showed features of atrophy, with wide areas of focal fibrosis surrounding smooth muscle cells. Type IV collagen was present around glands and small vessels, suggesting a thickening of the basal lamina. The expression of the fibrogenic cytokines TGFbeta and CTGF, ET-1, and the myofibroblast marker alpha-SMA was stronger in SSc patients than in controls.
CONCLUSION: A pronounced deposition of collagen, the presence of myofibroblasts, and increased expression of several profibrotic factors are important hallmarks in the stomach of patients with SSc. The fibrotic involvement of the gastric wall may account for muscle atrophy leading to stomach hypomotility in SSc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907149     DOI: 10.1002/art.22940

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  [Gastrointestinal involvement in systemic sclerosis. An underestimated complication].

Authors:  P Saar; T Schmeiser; I H Tarner; U Müller-Ladner
Journal:  Hautarzt       Date:  2007-10       Impact factor: 0.751

Review 2.  Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.

Authors:  S Kumar; J Singh; S Rattan; A J DiMarino; S Cohen; S A Jimenez
Journal:  Aliment Pharmacol Ther       Date:  2017-02-09       Impact factor: 8.171

3.  Profile of gastrointestinal involvement in patients with systemic sclerosis.

Authors:  T Schmeiser; P Saar; D Jin; M Noethe; A Müller; N Soydan; P D Hardt; C Jaeger; O Distler; E Roeb; R G Bretzel; U Müller-Ladner
Journal:  Rheumatol Int       Date:  2011-07-19       Impact factor: 2.631

4.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

5.  Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.

Authors:  Franco Cozzi; Giancarlo Parisi; Luca Ciprian; Arianna Bullo; Silvia Cardarelli; Michela Rizzo; Paolo Sfriso; Leonardo Punzi
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

Review 6.  Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation.

Authors:  Lidia La Barbera; Federica Macaluso; Serena Fasano; Giulia Grasso; Francesco Ciccia; Giuliana Guggino
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

7.  Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.

Authors:  Elizabeth R Volkmann; Yu-Ling Chang; Nashla Barroso; Daniel E Furst; Philip J Clements; Alan H Gorn; Bennett E Roth; Jeffrey L Conklin; Terri Getzug; James Borneman; Dermot P B McGovern; Maomeng Tong; Jonathan P Jacobs; Jonathan Braun
Journal:  Arthritis Rheumatol       Date:  2016-06       Impact factor: 10.995

8.  Gastrointestinal complications of systemic sclerosis.

Authors:  Xin-Ping Tian; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

9.  Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis.

Authors:  Nadine Binai; Steven O'Reilly; Bridget Griffiths; Jacob M van Laar; Thomas Hügle
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

10.  Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma.

Authors:  Agostino Di Ciaula; Michele Covelli; Massimo Berardino; David Q H Wang; Giovanni Lapadula; Giuseppe Palasciano; Piero Portincasa
Journal:  BMC Gastroenterol       Date:  2008-02-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.